GENEVA, Switzerland | THE INDEPENDENT | The United States Food and Drug Administration (FDA) has approved long-acting injectable lenacapavir for HIV prevention. The new medicine is administered by injection once every 6 months and is a significant step in improving prevention options for people at risk of HIV infection around the …
Read More »
Brussels, Belgium | XINHUA | The European Commission has signed a 63 million-euro contract with American pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir, for the treatment of COVID-19, it announced on Wednesday. The commission said in a statement that batches of Veklury will …
Read More »
By Agencies The Lancet, American Public Health Association, British HIV Association join AIDS Healthcare Foundation and other health advocates in concern over health impact of Gilead’s unproven HIV prevention pill AIDS Healthcare Foundation (AHF), America’s largest HIV/AIDS nonprofit medical provider, on Aug. 10 reaffirmed its opposition to the Food and …
Read More »
The Independent Uganda: You get the Truth we Pay the Price
